Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2025-12-26 @ 1:39 AM
Study NCT ID:
NCT01136733
Status:
COMPLETED
Last Update Posted:
2019-02-27
First Post:
2010-05-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-26
First Submit QC Date:
None
Study First Post Date:
2010-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-23
Results First Submit QC Date:
None
Results First Post Date:
2019-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2016-05-17
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-02-07
Last Update Post Date:
2019-02-27
Last Update Post Date Type:
ACTUAL